Position in GRFS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,727
+$362 QoQ
Shares Held
244
+67.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#145
of 164 holders
Holding Since
Mar 2022
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Global Retirement Partners, LLC holds $120,329,245 across 18 Drug Manufacturers - General names. GRFS ranks #17 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
30,536 | $36,625,797 | |
| 2 | ABBV |
AbbVie Inc.
|
73,217 | $18,424,325 | |
| 3 | JNJ |
Johnson & Johnson
|
67,123 | $17,047,228 | |
| 4 | MRK |
Merck & Co., Inc.
|
78,760 | $10,120,660 | |
| 5 | AMGN |
Amgen Inc
|
24,522 | $8,879,906 | |
| 6 | AZN |
Astrazeneca PLC
|
30,381 | $5,760,845 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
94,816 | $5,463,297 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
34,604 | $4,371,869 |
All Filings in GRFS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,727 | 244 | Shares | Sole | 2026-08-06 | |
| 2025-12-31 | $1,365 | 146 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,390 | 240 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $2,169 | 240 | Shares | Sole | 2025-08-12 | |
| 2024-12-31 | $1,785 | 240 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $5,274 | 594 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $3,495 | 554 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $2,364 | 354 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $485 | 42 | Shares | Sole | 2024-01-18 | |
| 2022-06-30 | $3,504 | 295 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $3,760 | 322 | Shares | Sole | 2022-07-14 | |
| No filing history on record for this holder in this stock. | ||||||